BioSpace News Archive

- Global Trial of RP-L102 Utilizing No Conditioning and “Process B” On Track for Early 2019 -

Accelerate Diagnostics, Inc. has joined with Sepsis Alliance to celebrate #GivingTuesday, November 27th, a global day of giving that harnesses the collective power of individuals, communities and organizations to encourage philanthropy and to celebrate generosity worldwide.

Grant program raises awareness of the role pets play for survivors - helping to increase the number of domestic violence shelters offering on-site pet facilities

Arrowhead Pharmaceuticals Inc. today announced that it will host a webcast and conference call on December 11, 2018, at 4:30 p.m. EST to discuss its financial results for the fiscal year ended September 30, 2018.

DUBLIN, /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma” or the “Company”) today announced dosing of the first subject in a Phase 1 clinical trial of TD-8236, a novel, inhaled, lung-selective pan-Janus kinase (JAK) inhibitor which has demonstrated potency in preclinical assessments.

NetraMark Corp. and Juvenescence Ltd. have partnered to form NetraPharma, a joint venture that is using artificial intelligence technologies to develop therapies that could slow, halt or potentially reverse aging.

MassRoots, Inc. announced today that MassRoots will be presenting at the 11th Annual LD Micro Main Event which will be held on December 4-6, 2018 at the Luxe Sunset Blvd Hotel in Los Angeles.

BioReliance® Viral and Gene Therapy Assay Portfolio wins award in Analytical/Test category

Select customers with GE CT scanners can now access and seamlessly integrate MaxQ’s revolutionary brain bleed detection software into their workflow via Smart Subscription

Autonomous Healthcare, Inc. has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase II grant for $746,668 to commercialize a clinical decision support fluid management system for intensive care unit (ICU) patients.